With the progression of diseases, modified cell–matrix interactions have major effects not only upon key cellular functions but also upon the structure of extracellular matrix and vasculature, which are two of the most prevalent fiber‐like structures in biological tissues. Unfortunately, quantitative approaches to assessing these structural changes are lacking. Herein, a multiparametric imaging system is established to resolve subtle organizational changes of collagen fibers and vasculature in disease progression. The pixel‐wise, automated waviness (paWav) is developed as a novel biomarker, and a multimodal analysis system combining paWav with orientation and alignment assessments is constructed. Aggregation‐induced emission luminogens (AIEgens) with second near‐infrared excitation or emission are developed for in vivo deep‐penetration vasculature imaging. The organization remodeling of cortical blood vessels in stroke in marmosets is quantitatively characterized using biologically excretable AIE dots that highlight the clinical translation potential, and a distance dependence law in vessel morphological remodeling is identified. Finally, the multiparametric analysis relying completely on collagen fiber signatures successfully differentiates cancerous from normal pancreatic tissues using a predictive classification approach. Collectively, the combined use of these structural changes in fibrillar tissue components may enable a better understanding of cell–matrix interactions in pathogenesis and identification of new potential treatment targets.
Ovarian cancer has the highest mortality rate among all gynecological cancers, containing complicated heterogeneous histotypes, each with different treatment plans and prognoses. The lack of screening test makes new perspectives for the biomarker of ovarian cancer of great significance. As the main component of extracellular matrix, collagen fibers undergo dynamic remodeling caused by neoplastic activity. Second harmonic generation (SHG) enables label-free, non-destructive imaging of collagen fibers with submicron resolution and deep sectioning. In this study, we developed a new metric named local coverage to quantify morphologically localized distribution of collagen fibers and combined it with overall density to characterize 3D SHG images of collagen fibers from normal, benign and malignant human ovarian biopsies. An overall diagnosis accuracy of 96.3% in distinguishing these tissue types made local and overall density signatures a sensitive biomarker of tumor progression. Quantitative, multi-parametric SHG imaging might serve as a potential screening test tool for ovarian cancer.
The endoplasmic reticulum (ER) is a highly dynamic membrane-bound organelle in eukaryotic cells which spreads throughout the whole cell and contacts and interacts with almost all organelles, yet quantitative approaches to assess ER reorganization are lacking. Herein we propose a multi-parametric, quantitative method combining pixel-wise orientation and waviness features and apply it to the time-dependent images of co-labeled ER and microtubule (MT) from U2OS cells acquired from two-dimensional structured illumination microscopy (2D SIM). Analysis results demonstrate that these morphological features are sensitive to ER reshaping and a combined use of them is a potential biomarker for ER formation. A new, to the best of our knowledge, mechanism of MT-associated ER formation, termed hooking, is identified based on distinct organizational alterations caused by interaction between ER and MT which are different from those of the other three mechanisms already known, validated by 100% discrimination accuracy in classifying four MT-associated ER formation mechanisms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.